ITMI20021455A0 - Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico - Google Patents
Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeuticoInfo
- Publication number
- ITMI20021455A0 ITMI20021455A0 IT2002MI001455A ITMI20021455A ITMI20021455A0 IT MI20021455 A0 ITMI20021455 A0 IT MI20021455A0 IT 2002MI001455 A IT2002MI001455 A IT 2002MI001455A IT MI20021455 A ITMI20021455 A IT MI20021455A IT MI20021455 A0 ITMI20021455 A0 IT MI20021455A0
- Authority
- IT
- Italy
- Prior art keywords
- lexitropsine
- phospholipide
- formulations
- preparation
- therapeutic use
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI001455A ITMI20021455A1 (it) | 2002-07-02 | 2002-07-02 | Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico |
| AU2003250849A AU2003250849A1 (en) | 2002-07-02 | 2003-06-26 | Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
| JP2004518585A JP2006505506A (ja) | 2002-07-02 | 2003-06-26 | レキシトロプシンのリン脂質複合体、その製造及び治療剤への使用 |
| US10/519,889 US20060067997A1 (en) | 2002-07-02 | 2003-06-26 | Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
| CA002491257A CA2491257A1 (en) | 2002-07-02 | 2003-06-26 | Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
| PCT/EP2003/006745 WO2004004691A1 (en) | 2002-07-02 | 2003-06-26 | Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
| EP03762519A EP1536771A1 (en) | 2002-07-02 | 2003-06-26 | Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI001455A ITMI20021455A1 (it) | 2002-07-02 | 2002-07-02 | Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMI20021455A0 true ITMI20021455A0 (it) | 2002-07-02 |
| ITMI20021455A1 ITMI20021455A1 (it) | 2004-01-02 |
Family
ID=11450127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT2002MI001455A ITMI20021455A1 (it) | 2002-07-02 | 2002-07-02 | Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060067997A1 (it) |
| EP (1) | EP1536771A1 (it) |
| JP (1) | JP2006505506A (it) |
| AU (1) | AU2003250849A1 (it) |
| CA (1) | CA2491257A1 (it) |
| IT (1) | ITMI20021455A1 (it) |
| WO (1) | WO2004004691A1 (it) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20031015A1 (it) * | 2003-05-20 | 2004-11-21 | Naxospharma S R L | Poli-(amminopirrolcarbossammidi) per uso nella profilassi e nel trattamento delle endoparassitosi animali e loro composizioni con ciclodestrine. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8517922D0 (en) * | 1985-07-16 | 1985-08-21 | Erba Farmitalia | Carboxamido derivatives |
| US6187572B1 (en) * | 1990-04-16 | 2001-02-13 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
| SK283760B6 (sk) * | 1996-10-15 | 2004-01-08 | The Liposome Company, Inc. | Farmaceutický prostriedok na dopravu bioaktívnych látok |
| DK1231910T3 (da) * | 1999-11-16 | 2009-08-31 | Oncozyme Pharma Inc | Pentamidin til behandling af cancer |
| NZ522839A (en) * | 2000-06-27 | 2004-11-26 | Genelabs Tech Inc | Novel compounds possessing antibacterial, antifungal or antitumor activity |
-
2002
- 2002-07-02 IT IT2002MI001455A patent/ITMI20021455A1/it unknown
-
2003
- 2003-06-26 WO PCT/EP2003/006745 patent/WO2004004691A1/en not_active Ceased
- 2003-06-26 US US10/519,889 patent/US20060067997A1/en not_active Abandoned
- 2003-06-26 CA CA002491257A patent/CA2491257A1/en not_active Abandoned
- 2003-06-26 EP EP03762519A patent/EP1536771A1/en not_active Withdrawn
- 2003-06-26 AU AU2003250849A patent/AU2003250849A1/en not_active Abandoned
- 2003-06-26 JP JP2004518585A patent/JP2006505506A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI20021455A1 (it) | 2004-01-02 |
| CA2491257A1 (en) | 2004-01-15 |
| EP1536771A1 (en) | 2005-06-08 |
| US20060067997A1 (en) | 2006-03-30 |
| JP2006505506A (ja) | 2006-02-16 |
| AU2003250849A1 (en) | 2004-01-23 |
| WO2004004691A1 (en) | 2004-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7714A (is) | Lyfjasamsetningar úr módafíníl | |
| NO20044402L (no) | Kombinasjonsbehandling av kemokine-medierte sykdommer | |
| PL374832A1 (pl) | Nowe podstawione benzoimidazolowe postacie dawkowe i sposoby ich stosowania | |
| CY2013043I1 (el) | Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv | |
| PT1485127E (pt) | Administração de agentes para o tratamento de inflamação | |
| CY2018005I2 (el) | Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης | |
| PL377931A1 (pl) | Farmaceutyczne preparaty donosowe oraz sposoby ich stosowania | |
| PT1513514E (pt) | Formulações tópicas de hidroximatairesinol | |
| FIU20060389U0 (fi) | Luusairauksien hoito | |
| CY2018006I2 (el) | Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας | |
| EP1476159A4 (en) | 9-NITROCAMPTOTHECIN POLYMORPHIC COMPOSITIONS AND FORMULATIONS AND METHODS OF USING THE SAME | |
| NO20044916L (no) | Preparater av sulfinylacetamid | |
| EP1502588A4 (en) | Light-stabilized soft capsule formulations | |
| EP1701726A4 (en) | Antimicrobial photodynamic therapy compound and method of use | |
| EP1560572A4 (en) | TOPICAL PARASITICIDE FORMULATIONS AND TREATMENT PROCEDURES | |
| IS6966A (is) | Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
| IS6967A (is) | Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
| EP1585519A4 (en) | HIGH CONCENTRATION OPIOID FORMULATIONS AND OPIOID DERIVATIVES | |
| IL162937A0 (en) | Pravastatin pharmaceutical formulations and methods of their use | |
| PL361518A1 (pl) | Zastosowanie substancji oraz kompozycja farmaceutyczna | |
| IS2707B (is) | Nýjar lyfjasamsetningar úr módafíníli | |
| EE200300501A (et) | Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid | |
| NO20041968L (no) | Anvendelse av cystationin | |
| EE200300328A (et) | IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks | |
| DE60238174D1 (de) | Fluoropolymere und Herstellungs- und Verwendungsverfahren |